Early cognitive decline in Creutzfeldt-Jakob disease associated with human growth hormone treatment

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 74, Issue 10, 2003, Pages 1412-1416

  Cordery, R J ^a   Hall, M ^a   Cipolotti, L ^a   Al Sarraj, S ^c   O'Donovan, D G ^d   Davidson, L ^e   Adlard, P ^e   Rossor, M N ^a,b  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; HYPOPHYSIS HORMONE;

ADULT; ARTICLE; BRAIN DYSFUNCTION; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC TEST; DISEASE SEVERITY; FEMALE; FRONTAL LOBE; GROWTH HORMONE DEFICIENCY; HUMAN; INTELLECTUAL IMPAIRMENT; LABORATORY TEST; MALE; MEMORY DISORDER; NEUROPSYCHOLOGY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; VISUAL IMPAIRMENT; VISUAL MEMORY;

ADULT; CADAVER; CEREBELLUM; COGNITION DISORDERS; CREUTZFELDT-JAKOB SYNDROME; DRUG CONTAMINATION; FEMALE; HUMAN GROWTH HORMONE; HUMANS; MALE; PITUITARY GLAND;

EID: 0141525287     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.74.10.1412     Document Type: Article

References (30)

1. Duffy P, Wolf J, Collins G, et al. Possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med 1974;290:692-3.
2. Will RG, Matthews WB. Evidence for case-to-case transmission of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 1982;45:235-8.
3. Bernoulli C, Siegfried J, Baumgartner G. Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery [letter]. Lancet 1977;i:478-9.
4. Thadani V, Penar PL, Partington J, et al. Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft. J Neurosurg 1988;69:766-9.
5. Powell-Jackson J, Kennedy P, Whitcombe EM, et al. Creutzfeldt-Jakob disease and administration of human growth hormone. Lancet 1985;ii:244-6.
6. Cochius JI, Burns RJ, Blumberg PC, et al. Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin. Aust NZ J Med 1990;20:592-3.
7. Brown P, Preece MA, Will RG. "Friendly fire" in medicine: hormones homografts, and Creutzfeldt-Jakob disease. Lancet 1992;340:24-7.
8. Brown P, Preece M, Brandel J-P, et al. latrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 2000;55:1075-81.
9. Fradkin JE, Schonberger LB, Mills JL, et al. Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United States. JAMA 1991;265:880-4.
10. Billette de Villemeur T, Deslys J-P, Pradel A, et al. Creutzfeldt-Jakob disease from contaminated growth hormone extracts in France. Neurology 1996;47:690-5.
11. Koch TK, Berg BO, De Armond SJ, et al. Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism. Possible relation to the administration of cadaveric human growth hormone. N Engl J Med 1985;313:731-3.
12. Croxson M, Brown P, Synek B, et al. A new case of Creutzfeldt-Jakob disease associated with human growth therapy in New Zealand. Neurology 1988;38:1128-30.
13. Marzewski DJ, Towfighi J, Harrington MG, et al. Creutzfeldt-Jakob disease following pituitary-derived human growth hormone therapy: a new American case. Neurology 1988;38:1131-4.
14. Masson C, Delalande I, Deslys JP, et al. Creutzfeldt-Jakob disease after pituitary-derived human growth hormone therapy: two cases with valine 129 homozygous genotype. Neurology 1994;44:179-80.
15. Weller RO, Steart PV, Powell-Jackson JD. Pathology of Creutzfeldt-Jakob disease associated with pituitary-derived human growth hormone administration. Neuropathol Appl Neurobiol 1986;12:117-29.
16. Wechsler D. Manual for the WAIS, revised. New York: Psychological Corporation, 1981.
17. Warrington EK, James M, Maciejewski C. The WAIS as a lateralizing and localizing diagnostic instrument: a study of 656 patients with unilateral cerebral lesions. Neuropsychologia 1986;24:1233-40.
18. Nelson HE. National adult reading test (NART): for the assessment of premorbid intelligence in patients with dementia. Windsor: NFER-Nelson, 1982.
19. Nelson HE, Willison JR. Re-standardisation of the NART against the WAIS-R. Windsor: Nelson, 1992.
20. Raven JC, Court JH, Raven J. The coloured progressive matrices. Oxford: Oxford Psychologists' Press, 1990.
21. Warrington EK. The recognition memory test. Windsor: NFER-Nelson, 1984.
22. Warrington EK. The Camden memory tests manual. Hove: Psychology Press, Hove, 1996.
23. McKenna P, Warrington EK. The graded naming test. Windsor: NFER-Nelson, 1983.
24. Warrington EK, James M. The visual perceptual and space perception battery. Bury St Edmunds: Thames Valley Test Co, 1991.
25. Shallice T, Evans ME. The involvement of the frontal lobes in cognitive estimation. Cortex 1978;14:294-303.
26. Weigl E. Zur psychologie sogenannter Abstraktionsprogesse. Z Psychol 1927;103:2-45, [Translatedby Rioch M and reprinted On the psychology of so called processes of abstraction J Abnorm Soc Psychol 1948;36:3-33].
27. Spreen O, Strauss E. A compendium of neuropsychological tests: administration, norms and commentary. Oxford: Oxford University Press, 1998.
28. Nelson HE. A modified card sorting task sensitive to frontal lobe defects. Cortex 1976;12:313-24.
29. Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999;46:224-33.
30. Schmahmann JD, Sherman JC. The cerebellar cognitive affective syndrome. Brain 1998;121:561-79.